Dermira Provides Launch Readiness Update for QBREXZA (glycopyrronium) Cloth for Primary Axillary Hyperhidrosis Biotech Investing
Chi-Med Announces the Approval of Fruquintinib Capsules for Previously Treated Colorectal Cancer in China Biotech Investing
PreveCeutical Develops Proprietary Extraction Protocol for Medical Cannabinoids to be Used with the Sol-gel Drug Delivery Program Biotech Investing
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy Biotech Investing
RedHill Biopharma Announces Completion of Enrollment for Confirmatory Phase III Study with TALICIA for H. pylori Infection Pharmaceutical Investing
Opiant Pharmaceuticals Announces Final Patient Enrolled in Phase 2 Clinical Trial Evaluating OPTN001 in Bulimia Nervosa Pharmaceutical Investing
Altimmune Announces Additional Positive Data from Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine Biotech Investing
Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera Microsphere Technology Pharmaceutical Investing
BeiGene Announces Acceptance of New Drug Application for Anti-PD-1 Antibody Tislelizumab in Hodgkin’s Lymphoma in China Pharmaceutical Investing
